Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase

Luyang Guo1, Takahisa Takino, Yoshio Endo

  • 1Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.

Insights

Membrane-type 1 matrix metalloproteinase (MT1-MMP) cleaves kidney injury molecule-1 (KIM-1), reducing its cell-surface levels. This cleavage by MT1-MMP abrogates KIM-1

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Kidney injury molecule-1 (KIM-1) is a transmembrane protein implicated in renal injury and cellular processes.
  • Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a key enzyme involved in extracellular matrix remodeling and cell invasion.

Purpose of the Study:

  • To investigate the interaction between KIM-1 and MT1-MMP.
  • To determine the functional consequences of KIM-1 cleavage by MT1-MMP on cellular behavior.

Main Methods:

  • Co-expression of KIM-1 and MT1-MMP in HEK293T cells.
  • Site-directed mutagenesis of KIM-1 to identify the cleavage site.
  • Stable transfection of HT1080 cells with KIM-1 and its mutants.
  • Treatment with MMP inhibitor (BB-94) and MT1-MMP siRNA.
  • Assessment of cellular functions including phagocytosis, adhesion, spreading, invasion, migration, and metastasis.

Main Results:

  • MT1-MMP cleaves the KIM-1 ectodomain at the juxtamembrane region.
  • MT1-MMP mediates the shedding of KIM-1 from the cell surface.
  • High KIM-1 expression enhances bacterial phagocytosis but reduces cell adhesion and spreading on collagen.
  • KIM-1 negatively regulates cellular functions involving collagen interaction, including invasion, migration, and metastasis.
  • MT1-MMP abrogates these KIM-1-mediated regulatory functions via cleavage and shedding.

Conclusions:

  • KIM-1 negatively regulates cellular functions, particularly those involving collagen interactions.
  • MT1-MMP plays a critical role in modulating KIM-1 function by cleaving and shedding its ectodomain.
  • The MT1-MMP-mediated cleavage of KIM-1 releases it from the cell surface, thereby abrogating its inhibitory effects on cellular functions.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...